NCT02394483 - Single Ascending Oral Dose Study of F901318 | Biotech Hunter

Enrollment

Participants

Timeline

Start Date

October 31, 2015

Primary Completion Date

September 30, 2016

Study Completion Date

September 30, 2016

Conditions

Invasive Aspergillosis

Interventions

DRUG

F901318 safety

Safety assessments

DRUG

F901318 tolerability

Tolerability assessments

DRUG

F901318 pharmacokinetics

Pharmacokinetic assessments

OTHER

Placebo safety

Safety assessments

OTHER

Placebo tolerability

OTHER

Placebo pharmacokinetics

Plaacebo pharmacokinetics

Trial Locations (1)

Simbec Orion, Merthyr Tydfil